Track-and-Trace System Is No Substitute for Drug Pedigrees to Thwart Gray Market, Lawmakers Say

Some Democratic lawmakers are pushing for a drug pedigree system to combat potential “gray marketing” of shortage drugs, arguing that a national track-and-trace system would not be enough to secure the supply chain. A track-and-trace system requiring only lot-level tracing “would provide no information about who takes custody of these drugs after the lot is opened and individual units are distributed,” according to Sen. John Rockefeller (D-W.Va.) and Rep. Elijah Cummings (D-Md.).
Drug Industry Daily